PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
1.760
+0.120 (7.32%)
Dec 26, 2024, 12:08 PM EST - Market open
PDS Biotechnology Employees
PDS Biotechnology had 25 employees as of December 31, 2023. The number of employees decreased by 1 or -3.85% compared to the previous year.
Employees
25
Change (1Y)
-1
Growth (1Y)
-3.85%
Revenue / Employee
n/a
Profits / Employee
-$1,622,250
Market Cap
65.84M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 25 | -1 | -3.85% |
| Dec 31, 2022 | 26 | 4 | 18.18% |
| Dec 31, 2021 | 22 | 7 | 46.67% |
| Dec 31, 2020 | 15 | 0 | - |
| Dec 31, 2019 | 15 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| NeueHealth | 1,252 |
| LakeShore Biopharma | 758 |
| Vor Biopharma | 168 |
| Hyperfine | 131 |
| RAPT Therapeutics | 131 |
| DBV Technologies | 105 |
| Invivyd | 95 |
| IceCure Medical | 77 |
PDSB News
- 20 days ago - PDS Biotechnology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - PDS Biotech to Host Key Opinion Leader Event on December 17 at 12 p.m. ET - GlobeNewsWire
- 6 weeks ago - PDS Biotechnology Corporation (PDSB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - PDS Biotech to Announce Third Quarter Financial Results on November 14, 2024 at 8:30 a.m. Eastern Time - GlobeNewsWire
- 3 months ago - PDS Biotech Announces 36-Month Overall Survival Rate of 84.4% in Locally Advanced Cervical Cancer Patients Treated with Versamune® HPV and Chemoradiation - GlobeNewsWire
- 3 months ago - PDS Biotechnology: Continuing The Holding Pattern - Seeking Alpha
- 3 months ago - PDS Biotech to Present Updated VERSATILE-002 Data at ESMO Congress 2024 - GlobeNewsWire
- 4 months ago - PDS Biotech to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire